Dermatofibroma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) Tags: Replaced Visual edit: Switched |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{Homa}} | {{CMG}};{{AE}}{{Homa}} | ||
== Overview == | == Overview == | ||
Dermatofibroma is primarily diagnosed based on the [[clinical]] presentation and history. | Dermatofibroma is primarily [[Diagnosis|diagnosed]] based on the [[clinical]] presentation and [[History and Physical examination|history]]. | ||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
=== Study of choice === | === Study of choice === | ||
Dermatofibroma is primarily diagnosed based on the [[clinical]] presentation and history. | Dermatofibroma is primarily [[Diagnosis|diagnosed]] based on the [[clinical]] presentation and [[History and Physical examination|history]]. | ||
==References== | ==References== | ||
Revision as of 15:50, 27 August 2019
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma diagnostic study of choice |
|
Risk calculators and risk factors for Dermatofibroma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Dermatofibroma is primarily diagnosed based on the clinical presentation and history.
Diagnostic Study of Choice
Study of choice
Dermatofibroma is primarily diagnosed based on the clinical presentation and history.